Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

German expert: screen pregnant women for diabetes:

This article was originally published in Clinica

Executive Summary

A leading German obstetrician has called for pregnant women to be screened for diabetes after the 24th week, using a glucose tolerance test. Professor Andreas Plagemann from Berlin's Charite hospital said many young mothers were overweight or obese, but were unaware of their condition's link with diabetes. Prof Plagemann said that, according to calculations, testing could spare some 80,000 children born to diabetic mothers annually in Germany from the possible consequences of contracting diabetes. At a cost of only E6 ($6.70), the glucose tests would, in effect, pay for themselves, because the statutory health insurance funds currently spend more than E18bn per year to treat diseases linked with being overweight.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT063159

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel